体外膜肺氧合在新型冠状病毒感染患者中的应用。
Use of Extracorporeal Membrane Oxygenation for Patients with Coronavirus Disease 2019 Infection.
机构信息
Division of Thoracic Surgery, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Division of Thoracic Surgery, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
出版信息
Adv Surg. 2024 Sep;58(1):249-273. doi: 10.1016/j.yasu.2024.05.003. Epub 2024 Jun 29.
The coronavirus disease 2019 (COVID-19) pandemic was a cataclysmic event that infected over 772 million and killed over 6.9 million people worldwide. The pandemic pushed hospitals and society to their limits and resulted in incredibly severe respiratory disease in millions of people. This severe respiratory disease often necessitated maximum medical therapy, including the use of extracorporeal membrane oxygenation. While our understanding of COVID-19 and its treatment continue to evolve, we review the current evidence to guide the care of patients with severe COVID-19 infection.
2019 年冠状病毒病（COVID-19）大流行是一场灾难性事件，感染了全球超过 7.72 亿人，导致超过 690 万人死亡。大流行使医院和社会承受了巨大压力，导致数百万人出现了极其严重的呼吸道疾病。这种严重的呼吸道疾病通常需要最大限度的医疗治疗，包括使用体外膜氧合。虽然我们对 COVID-19 及其治疗的认识仍在不断发展，但我们回顾了现有证据，以指导严重 COVID-19 感染患者的护理。
Zotero 插件